*** Notice: For the protection of property rights, this catalog is available for online browsing only. Please drop us a line if you would like to receive a copiable version of this catalog. Thank You!

PHARMACY

ADVANCES IN MANAGING & TREATING ATTENTION DEFICIT DISORDER

Joseph P. Horrigan, MD; L. Jarrett Barnhill, Jr., MD; William Lord Coleman, MD
Attention Deficit Hyperactivity Disorder Throughout the Life Cycle; Psychiatric Comorbidity; The Impact of Attention Deficit on Learning.

Item no.	:	HV01240203
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

ADVANCES IN MANAGING ALZHEIMER'S DISEASE

Kevin M. Furmaga, PharmD; Michael Koronkowski, PharmD; Vinod Kumar, MD, MRC
Topics include: Pathophysiology and Non-Cognitive Symptoms of Alzheimer's Disease; Cognitive Symptoms of Alzheimer's Disease; Future Directions in Drug Therapy for Alzheimer's Disease.

Item no.	:	DZ01240091
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

ADVANCES IN PHARMACEUTICAL CARE FOR PATIENTS WITH ASTHMA

Program provides participants w/ an update on new guidelines for the management of asthma, roles that pharmacists can play in the treatment of patients w/ asthma, and the role that medications affecting leukotriene synthesis or action may play in therapy.

Item no.	:	EB01240128
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

ADVANCES IN THE MANAGEMENT OF THE SIDE EFFECTS OF CHEMOTHERAPY

Stephen L. Huber, MS, RPh; Cynthia Radford; Steven M. Grunberg, MD
This program features leading healthcare professionals giving presentations on the latest advances in the management of the side effects of chemotherapy. Discussions will include information on pharmacoeconomics of antiemetic therapy in oncology and appropriate use of antiemetic therapy. Specific topics include: Enhancing the Value of Antiemetics in Oncology; Reimbursement Environment in Antiemetic Therapy; Challenges in Antiemetic Therapy.

Item no.	:	VA01240021
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

ADVANCES IN TREATING SOCIAL PHOBIA

Atezaz Saeed, MD; Timothy Bruce, PhD
Recognize and formally diagnose social phobia using DSM-IV; Differentiate social phobia from other primary and secondary anxiety disorders; Identify the disorders which tend to be commonly comorbid with social phobia; understand indications for drug therapy, cognitive behavior therapy, and combined treatment for social phobia; Describe classes of drugs most appropriate in treatment and first line treatments and follow-up treatment in case of non-response.

Item no.	:	SY01240200
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

AIDS RESEARCH FORUM: MANAGEMENT OF PATIENTS WITH ADVANCED HIV INFECTION

Stephen Nightingale, MD; Kathleen Squires, MD
Advances in the management of HIV infection, including new strides in delaying the onset of full-blown AIDS. Studies involving drugs utilized in both a prophylactic and therapeutic capacity are discussed.

Item no.	:	BR01240013
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

CLOSER LOOK AT THE DIAGNOSIS & TREATMENT OF SCHIZOPHRENIA, A

Mark D. Watanabe, PharmD, PhD; S. Charles Schulz, MD; Peter F. Buckley, MD
Define the demographic characteristics of schizophrenia; Appreciate the core diagnostic features of schizophrenia; Discuss which conditions mimic the presentation of schizophrenia; Understand the role of ancillary tests and other information in differentiating schizophrenia from neurological conditions; Identify new drugs available for full syndrome of schizophrenia; Distinguish the difference between the effects of traditional drugs and new drugs; Describe the current theories proposed for the pathogenesis of schizophrenia and their implications for rational drug therapy.

Item no.	:	SH01240202
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

COMPENSATION FOR PROFESSIONAL SERVICES IN DELIVERY OF PHARMACEUTICAL CARE

Michael T. Rupp, PhD, RPh
Discussion on the status of recent initiatives to create a national standard for the routine documentation and transmission of clinical and billing information related to the delivery of pharmaceutical care between pharmacy providers and third-parties.

Item no.	:	GA01240208
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

CURRENT CONCEPTS IN HYPERTENSION MANAGEMENT

Item no.	:	KD01240196
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

DOSE RESPONSE RELATIONSHIP OF 5HT3 ANTIEMETICS, THE

Celeste Lindley, PharmD; Steven M. Grundberg, MD; John D. Hainsworth, MD; Stephen L. Huber, MS, RPh
Learn about determining the emetogenic potential for chemotherapy agents; review new class system and algorithm for determining emetogenic potential of combo chemotherapy regimens. Discussions include the rationale for stratification of antiemetic dosage based on the emetogenicicity of the chemotherapy regimen; appreciating the cost and revenue comparisons for the 5HT3 antiemetics based on dosing considerations and identifing strategies for enhancing the antiemetics in a variety of practice settings.

Item no.	:	EO01240017
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

EVALUATION AND UTILIZATION OF PHARMACOECONOMIC RESEARCH

Thomas O'Conner, PharmD, MBA; Michael A. Mancano, PharmD; Barbara Goppold, RPh
Identify the four basic types of pharmacoeconomic analyses; Discuss and categorize the types of relevant costs; Evaluate the criteria for a well designed pharmacoeconomic study; Interpret study results; Suggest the most appropriate treatment modality based upon study results; Identify the potential value and uses of pharmacoeconomic research in the managed care environment.

Item no.	:	TK01240207
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

FORMULARY DEVELOPMENT AND COMPLIANCE

Perry Cohen; Joseph Ober, Pharm.D; Sharon Montgomery, MA, RPh; J. Russell May, PharmD
Explains the evolution of managed care, discusses the important issues facing managed care including outcomes, disease management, and pharmacoeconomics; formulary development; explains the impact of the formulary on the pharmacist, hospital and community.

Item no.	:	GH01240151
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

HEALTH OUTCOMES RESEARCH

Barry Kass, RPh, MBA; Judith Barr, ScD; Gerald E. Schumacher, PharmD, PhD
This program provides an introduction to health outcomes research with an examination of the links among structure, process, and outcomes in clinical interventions and health delivery systems. System-based and patient-centered outcomes will be discussed with administrative, clinical and economic examples drawn from therapeutic drug monitoring, DUR/DUE, and other pharmacy-related topics.

Item no.	:	EB01240153
Format	:	DVD
Duration	:	120 minutes
Price	:	USD 209.00

IMPROVING CARDIOVASCULAR RISK

Robert B. Supernaw, PharmD; Mary J. Ferrill, PharmD; Sian Carr-Lopez, PharmD
Hyperlipidemia: Reducing Risk by Reducing Cholesterol; Should We Be Treating Patients With Medication?; Hypertension and Cardiovascular Risk: Will Controlling Blood Pressure Reduce the Risk?

Item no.	:	WE01240052
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

ISSUES IN AMINOGLYCOSIDE THERAPY

Vanessa L. Kluth, PharmD; Melissa Cordell, RN; Ed Septimus, MD
Identify important factors when choosing the appropriate antimicrobial agent for a given infection; Describe the mechanism of action and spectrum of active aminoglycosides; Discuss rationale for once-daily dosing; State appropriate timing of drug sampling as it relates to aminoglycoside dosing; Understand the importance of the interpretation of results.

Item no.	:	GD01240163
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

MANAGEMENT OF THE SIDE EFFECTS OF CHEMOTHERAPY

Steven M. Grunberg, MD; John D. Hainsworth, MD; Paul J. Hesketh, MD; Jane Nolte, PharmD
Pharmacoeconomics of antiemetic therapy, oral antiemetics replacing IV antiemetics, appropriate use of antiemetic therapy, and the management of cisplatin-induced delayed emesis

Item no.	:	EB01240029
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

MANAGING HYPERLIPIDEMIA TO MEET PATIENT CARE NEEDS

Bogomir M. Kuhar, PharmD; Jean-Venable 'Kelly' R. Goode, PharmD, BCPS; Kim Malone, BS
Describe current rationale and epidemiology of cholesterol management. Review cardiovascular risk factors and current NCEP guidelines for treatment. List treatment approaches to achieving NCEP goals. List drug strategies and the major adverse reactions in treating hyperlipidemia. List the benefits of a pharmacy-based lipid screening and monitoring program. Explain procedures necessary for making a hyperlipidemia clinic. Identify the strategies needed to implement & keep a pharmacy-based clinic. Develop a marketing plan for a pharmacy-based clinic.

Item no.	:	GH01240197
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

MEDICAL SCIENCE HORIZONS: RECOMBINANT TECHNOLOGY

Savio L. C. Woo, PhD; Alan Bernstein, PhD; Nelson A. Wivel, MD
Gene Therapy in the 21st century; Ethical considerations of the replication of genes in therapy; Diseases currently in treatment.

Item no.	:	EV01240015
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 209.00

NAFTA & THE U.S. PHARMACIST

Barry Coleman, RPh (Moderator); T. L. Vordenbaumen, Sr., RPh; Orville A. Wagner; Dr. Jaime Kravzov
A prominent international faculty that will "explore the pharmacy implications of NAFTA with an emphasis on education and practice needs, as well as quality and pricing in drug manufacturing".

Item no.	:	CH01240209
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

NEW THERAPEUTIC ADVANCES IN THE MEDICAL TREATMENT OF GLAUCOMA

Richard G. Fiscella, RPh, MPH; Richard A. Quinones, MD; Bruce I. Gaynes, OD, MS, PharmD
Define glaucoma and explain disease manifestation; List different treatment options available; Describe the traditional medical treatments available; Understand the new medical agents available and how they may change therapeutic options for the treatment of glaucoma.

Item no.	:	BK01240189
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

PHARMACEUTICAL CARE: QUALITY OF LIFE

Walter J. Curran, Jr., MD; David S. Ettinger, MD; Chandra P. Belani, MD; Dawn Moose, MD
Integration of Chemotherapy and Radiation for Non-Small Cell Lung Cancer; New Drugs in Treatment of NSCLC; Recent Improvements in the Management of NSCLC; Management of Anorexia and Cachexia for Patients w/ NSCLC

Item no.	:	BU01240149
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

PHARMACIST'S ROLE IN OPTIMIZING PATIENT COMPLIANCE, THE

Thomas O'Conner, PharmD, MBA; Elaine D. Mackowiak, PhD; Robert S. Thompson, PhD
Patient Non-Compliance, A Major Obstacle to Improving Health Care Outcomes; Counseling and Reinforcing Proper Self-Medication; Compliance Devices

Item no.	:	CA01240205
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

PHARMACIST'S ROLE IN THE MANAGEMENT OF HIV DISEASE

Dale Kummerle, PharmD; Victoria Earlywine, PharmD; Stephen Piscitelli, PharmD
Compliance with HIV Medications; Drug Interaction with HIV Medications; Practical Considerations: Circumventing Side Effects

Item no.	:	EU01240006
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

PHARMACOLOGY OF NEUROPATHIC PAIN: CORTICOSTEROIDS, ANESTHETICS, ANTICONVULSANTS

Mark Boswell, MD

Item no.	:	EV01240158
Format	:	DVD
Duration	:	30 minutes
Price	:	USD 189.00

PHARMACY COMPOUNDING

Art Matthys, RPh; William Letender, MS, RPh; Dave Mason, RPh; Loyd Allen, PhD
Define the terms pharmacy, manufacturing, compounding, and triad; Identify areas where pharmacists can solve non-compliance problems using compounding services; List the unique dosage forms that are available to healthcare professionals. Understand how pharmacists meet the unique needs of patients at their practice sites; List the factors that exempt pharmacists from the Federal Food and Drug and Cosmetic Act; Realize the value of compounding services in terms of patient compliance and patient needs. Identify areas of practice could potentially benefit compounding; Select a course of action to take when filling a compounded prescription .

Item no.	:	DK01240199
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

PHARMACY UPDATE: ADVANCES IN DETERMINING & TREATING SCHIZOPHRENIA

Mark Watanabe, PharmD; Barbara Poddig, PharmD, BCPP; LaGenia Bailey, PharmD; Mark E. Schneiderhan, PharmD, BCPP
Describe the therapeutic goals of using typical antipsychotic agents; Understand the common side effects of typical antipsychotic agents; Identify characteristics of "High potency" vs "Low potency" antipsychotic agents.

Item no.	:	PH01240204
Format	:	DVD
Duration	:	90 minutes
Price	:	USD 249.00

PSYCHIATRY UPDATE: PANIC DISORDER

S. A. Saeed, MD; William C. Sanderson, PhD
Treatment of Panic Disorder and Diagnosis of Panic Disorder

Item no.	:	PF01240206
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

RATIONALE FOR ACHIEVING OPTIMAL GLYCEMIC CONTROL IN DIABETIC PATIENTS

R. Keith Campbell, RPh, FASHP, CDE; Julie C. Oki, PharmD, BCPS
Provide an update on the treatment of diabetes, including a review of the rationale for and means of achieving optimal glycemic control. Specific topics covered include: Discussion of the rationale for achieving optimal glycemic control in both type I and type II diabetic patients; Recent advances which may aid in achieving optimal glycemic control in type II diabetic patients; Methods to improve glycemic control in patients with type I diabetes.

Item no.	:	EV01240081
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

ROLE OF THE PHARMACIST IN COMPLIANCE ENHANCEMENT

Describes the methods of detecting and predicting non-compliance, identifies the economic consequences of non-compliance to healthcare generally and in pharmacy practice, and discusses how to choose interventions best suited to enhance compliance.

Item no.	:	FK01240210
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

THERAPEUTIC MANAGEMENT OF CONGESTIVE HEART FAILURE

J. Herbert Patterson, PharmD; Michael B. Bottorff, PharmD; Barry Bleske, PharmD
Pathophysiology of heart failure and it's role in contributing to the morbiity and mortality of heart failure; be able to identify the most appropriate therapy for a patient to optimize outcomes; when a specific therapy is contraindicated, be able to identify alternate appropriate therapies to optimize therapeutic outcomes. Be able to list potential drug therapies that may be useful for heart failure.

Item no.	:	BF01240045
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

THERAPEUTIC NONCOMPLIANCE IN MEDICATION USAGE

Frederick Pfeiffer, PharmD; Richard Herrier, PharmD, CPE
Assess the impact of medication nonadherance to the overall cost of healthcare in the US; Determine the need for patient education regarding medications for hypertension as it relates to drug defaulting; Determine the role of common annoying side effects with diuretics in the perpetuation of therapeutic nonadherance; Describe three misconceptions regarding compliance issues; List three main factors that are required for optimal patient compliance.

Item no.	:	TY01240198
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

USING CLAIMS DATA IN HMO TO ASSESS MEDICATION USAGE EMPHASIZING APPROPRIATE PRESCRIBING

Edward P. Armstrong, PharmD; Frederick Pfeiffer, RPh, MS, PharmD; Tim Sawyers, RPh, MBA, CDE
Provide information for using claims data to assess drug therapy; Analyze claims data to determine non-adherence to chronic medications; Understand how to access medical and pharmacy claims; Differentiate medical from pharmacy claims data and report generation; Identify specific depressions management problems in a managed care setting.

Item no.	:	BE01240201
Format	:	DVD
Duration	:	60 minutes
Price	:	USD 209.00

Email:
inquiry@learningemall.com

Websites:
http://www.learningemall.com [ English ]
http://www.learningemall.com.hk [ Chinese ]